Delivery Order SPE2DE21D7020-SPE2D625F0JV2
- Not listed
- Boston Scientific Corp was awarded a delivery order valued at $92,950.00 for the FARAPULSE Pulsed Field Ablation System on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract is fixed-price with economic price adjustment and carries no set-aside designation. The award was funded through the Defense Health Agency's Medical Supply Chain and will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The FARAPULSE system represents a...
- Boston Scientific Corp has been awarded a delivery order contract valued at $58,675 for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. The award was made by the Defense Health Agency's Medical Supply Chain on September 12, 2025, with no set-aside designation. The contract utilizes fixed-price pricing with economic price adjustment terms and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order...
- Boston Scientific Corp was awarded a $49.8K fixed-price delivery order with economic price adjustment on July 11, 2025, for the FARAPULSE Pulsed Field Ablation System. The contract is funded through the Defense Health Agency's Medical Supply Chain program and extends through July 18, 2025. The system will be delivered to Marlborough, Massachusetts, where Boston Scientific maintains its primary operations. This delivery order is not set aside for any specific business classification and...
- Boston Scientific Corp was awarded a $84.5K delivery order by the Defense Health Agency's Medical Supply Chain on September 12, 2025, for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. The contract employs fixed-price pricing with economic price adjustment terms and carries no set-aside designation, indicating open competition. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts, where the company...
- The Defense Health Agency's Medical Supply Chain has awarded a $84.5K delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. This fixed-price delivery order with economic price adjustment will be performed at Boston Scientific's Marlborough, Massachusetts location. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The FARAPULSE...
- The U.S. Defense Health Agency's Medical Supply Chain awarded a $45,000 fixed-price delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, effective through August 14, 2025. This delivery order, which includes economic price adjustment provisions, represents Boston Scientific's continued supply of advanced cardiac intervention technologies to the federal healthcare system. The award was made without a set-aside designation, allowing Boston Scientific to...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, valued at approximately $52K with a fixed-price contract that includes economic price adjustment provisions. The delivery order was issued on September 8, 2025, with an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No small business set-aside was utilized for...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order valued at $92,950 to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This delivery order, with a fixed-price contract structure that includes economic price adjustment provisions, was awarded on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award represents a continuation...
- The Defense Health Agency's Medical Supply Chain issued a delivery order valued at $92,950 on August 11, 2025, to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by August 18, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The contract utilizes no set-aside designation, allowing the award to be made through open competition. As a...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp valued at $16,900 for the FARAPULSE Pulsed Field Ablation System. The contract, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. Performance will be conducted at Boston Scientific's Marlborough, Massachusetts facility, where the company manufactures advanced...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0JV2Delivery Order
Boston Scientific Corp has been awarded a delivery order valued at $48.8K for the FARAPULSE Pulsed Field Ablation System under a fixed-price contract with economic price adjustment provisions. The contract, awarded on June 2, 2025, with an ultimate completion date of June 10, 2025, is being funded through the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a continuation of Boston Scientific's significant role as a critical supplier of advanced cardiovascular medical technologies to federal healthcare agencies, including the Defense Health Agency and Department of Veterans Affairs. The FARAPULSE system is a specialized cardiac ablation device used in interventional cardiology procedures. This award carries no set-aside designation, indicating Boston Scientific competed openly in the federal marketplace. As a globally recognized medical technology company, Boston Scientific maintains multiple indefinite delivery vehicles and blanket purchase agreements with federal agencies, enabling rapid response to evolving healthcare needs. The company's established presence within the Defense Health Agency's supply chain and its track record of delivering sophisticated medical devices position it as a valued provider of critical cardiac intervention technologies to the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.8k | 6/2/25 |